Slovenia

In addition to a EUR49mn (US$61mn) reduction in its healthcare budget in early June, the Slovenian Ministry of Health has now proposed a series of pharmaceutical cost-containment measures.... 2010-07-02

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15

Slovenian pharmaceutical company Lek, a division of Novartis's generic arm Sandoz, has opened a new US$3.8mn biopharmaceutical production facility to produce biosimilar epoetin alfa.... 2010-03-12

The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will... 2010-03-09

Slovenian generic drugmaker Krka plans to continue its strong organic growth strategy during 2010, while also eyeing potential takeover opportunities. Chief Executive Jože Colarič... 2010-02-04

BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected... 2010-01-05

Slovenia-based generic drugmaker Krka has been criticised by Lithuania's Ethical Pharmaceutical Companies Association (EFA) for failing to comply with the country's 'Code of Pharmaceutical... 2010-01-04

BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings.... 2009-10-30

Half-yearly results from Slovenian pharmaceutical firm Krka have highlighted strong performance in the company's Western Europe and Overseas (which includes any markets outside of... 2008-08-26

The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the... 2008-07-31